|
1 Bouchardy C, Fernandez S, Merglen A, et al. Increased risk of second cancer among patients with ovarian borderline tumors. Gynecol Oncol, 2008, 109(2)：210–214.
|
|
2 Ayhan A, Guvendag Guven ES, Guven S, et al. Recurrence and prognostic factors in borderline ovarian tumors. Gynecol Oncol, 2005，98 (3)：439–445.
|
|
3 Ayhan A, Guven S, Guven ES, et al. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol Scandin，2007，86(4)：484–490.
|
|
4 Tang J, Lai J, Geng J, et al. Preoperative sonographic features of borderline tumors of the ovary. Chin J Clin Obstet Gynecol，2007，8(3)：172–174.[唐军，赖娟，耿京，等．术前诊断卵巢交界性肿瘤的超声特征．中国妇产科临床杂志，2007，8(3)：172–174.]
|
|
5 Qu YJ，Han YY，Geng HG，et al. Clinical pathological analysis of epithelial borderline tumor of the ovary.Biomagnetism，2006，6(1)：39–40.[曲延峻，韩燕燕，耿红光，等.56例卵巢上皮性交界性肿瘤的临床和病理分析．生物磁学，2006，6(1)：39–40.]
|
|
6 Berman JJ. Borderline ovarian tumor workshop, Bethesda, Maryland, 2003. Hum Pathol, 2004，35：907–909.
|
|
7 Zhen WX, Wang HJ.Consensus and dispute of borderline ovarian tumours. J Clin Exp Pathol，2007, 23 (3)：257–261.[郑文新，王慧君．卵巢交界性肿瘤的共识和争议．临床与实验病理学杂志，2007，23(3)：257–261.]
|
|
8 Seidman JD, Soslow RA, Vang R, et al. Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol, 2004，35(8)：918–933.
|
|
9 Liu XM.Obstetrical and gynecological surgery. 3 rd ed.Beijing：People's Medical Publishing House，2003，234–235.[刘新民. 妇产科手术学.3版．北京：人民卫生出版社，2003，234–235.]
|
|
10 Verbruggen MB, Verheijen RH, van de Goot FR, et al. Serious borderline tumor of the ovary presenting with cervical lymph node involvement: A report of 3 cases. Am J Surg Pathol, 2006, 30 (6)：739–743.
|
|
11 Tinelli R, Tinelli A, Tinelli FG, et al. Conservative surgery for borderline ovarian tumors: A review. Gynecol Oncol, 2006，100 (1)：185–191.
|
|
12 Morris RT, Gershen son DM, Silva EG, et al. Outcome and reproductive function after conservative surgery for borderline ovarian tumours. Obstet Gynecol, 2000, 95 (4)：541–547.
|
|
13 Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumours with particular interest to persistence, recurrence, and progression to invasive carcinoma：A prospective study. J Clin Oncol, 2001, 19 (10)：2658–2664.
|
|
14 Fauvet R, Poncelet C, Boccara J, et al. Fertility after conservative treatment for borderline ovarian tumours：A French multicenter study. Fertil Steril, 2005, 83 (2)：284–290.
|
|
15 Zhang JM. Ovariopathy pathology.Nanchang：Science Technique Publishing House，2006，172–174.[张建民. 卵巢病理学. 南昌：江西科学技术出版社，2006，172–174.]
|
|
16 Hart WR. Borderline epitheliel tumors of the ovary. Mod Pathol, 2005, 18：33–50.
|
|
17 Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumours with particular interest to persistence, recurrence, and progression to invasive carcinoma：A prospective study. J Clin Oncol, 2001, 19(10)：2658–2664.
|
|
18 Camatte S，Morice P, Pautier P, et al. Fertility results after conservative treatment of advanced stage serous borderline tumours of the ovary. BJOG, 2002, 109 (4)：376–380.
|
|
19 Chan JK, Lin YG，Loizzi V, et al. Borderline ovarian tumours in reproductive–age women: Fertility–sparing surgery and outcome. J Rep rod Med, 2003, 48 (10)：756–760.
|
|
20 Maneo A, VignaliM, Chiari S, et al. Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol, 2004，94 (2)：387–392.
|
|
21 Fauvet R, Boccara J, Dufournet C, et al. Laparoscopic management of borderline ovarian tumour. Ann Oncol, 2004, 16(3)：403–410.
|
|
22 Xiong YH，Hou XP，Zhu B. Postoperative chemotherapy in treatment of borderline ovarian tumors. Pract J Cancer，2006，21(1)：57–58.[熊员焕，侯晓萍，朱波．交界性卵巢肿瘤辅助化疗的临床观察．实用肿瘤杂志，2006，21(1)：57–58.]
|
|
23 Morice P, Camatte S，Wicart–Poque F, et al. Results of conservative management of epithelial malignant and borderline epithelial ovarian tumour. Hum Reprod Update, 2003, 9(2)：185–192.
|
|
24 McKenney JK, Balzer BL, Longacre TA. Lymph node involvement in ovarian serious tumors of low malignant potential (borderline tumors): Pathology, prognosis, and proposed classification. Am J Surg Pathol, 2006, 30 (5)：614–624.
|
|
25 Yokoyama Y，Moriya T, Takano T, et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer, 2006, 94 (11)：1586–1591.
|
|
26 Ren J, Peng Z, Yang KA. Clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol Oncol，2008, 110(2)：162–167.
|